Poorly controlled diabetes — not diabetes itself — triples dementia risk, study finds
By
Alicia Lasek
Oct 13, 2021
In the absence of a cure for dementia, prevention is vital, and a new study offers evidence that this can be done through the careful control of diabetes, investigators say.
Seniors should not begin taking aspirin to prevent heart disease: New U.S. guidance
By
Alicia Lasek
Oct 13, 2021
The risk of bleeding caused by aspirin in adults age 60 and older cancels out the benefits of preventing heart disease, an influential U.S. task force stated Tuesday.
Clinical briefs for Wednesday, Oct. 13
By
Alicia Lasek
Oct 13, 2021
Governor bans vaccine mandates by ‘any entity’ in Texas … Moderna’s COVID-19 vaccine may not meet booster dose criteria, FDA scientists say … A wrenching farewell: Bidding adieu to my primary...
Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation
By
Alicia Lasek
Oct 12, 2021
The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...
Feds asked to OK what could be the first COVID-19 antiviral pill
By
Alicia Lasek
Oct 12, 2021
If authorized for emergency use, certain patients could take molnupiravir at home after COVID-19 diagnosis, the drug’s developers said.
Recovered COVID-19 patients may have a booster shot edge, research finds
By
Alicia Lasek
Oct 12, 2021
Recovered COVID-19 patients may gain more protection from a booster shot when compared to their peers who haven’t caught the virus. Researchers say the findings could help determine ideal booster vaccine...
Clinical briefs for Tuesday, Oct. 12
By
Alicia Lasek
Oct 12, 2021
As antipsychotic stewardship backslides in nursing homes, risks mount … Don’t pause osteoporosis drug risedronate for more than two years, new research suggests … CDC advisers plan review of more...
C. diff may sneak in on soles of shoes, sampling study shows
By
Alicia Lasek
Oct 08, 2021
Community exposure to the superbug Clostridiodes difficile may be more common than previously thought, with a surprising amount of spores carried on the soles of shoes, researchers say.
No safety issues: Fluzone shot can be co-administered with a Moderna COVID vaccine booster, Sanofi says
By
Alicia Lasek
Oct 08, 2021
Older adults have the same immune response to each drug when they are co-administered as when given separately. This is also true of safety and tolerability, the drugmaker says.
A first? COVID antibody therapy with full-year protection is up for FDA authorization
By
Alicia Lasek
Oct 08, 2021
Drugmaker AstraZeneca has asked the FDA to authorize what it says could be the first long-acting monoclonal antibody drug therapy for the prevention of COVID-19 in at-risk patients.